Market Overview - On October 31, the A-share market continued to show a high-level consolidation trend, with the Shanghai Composite Index closing at 3954.79 points, down 0.81% [6] - The Shenzhen Component Index and the ChiNext Index fell by 1.14% and 2.31%, respectively [6] - The innovative drug sector performed strongly, with stocks like Sanofi and others hitting the daily limit [6] Bond Market - The 30-year Treasury futures main contract rose by 0.42%, closing at 116.680 yuan, an increase of 0.490 yuan [6] - The 10-year Treasury futures closed at 108.680 yuan, up 0.045 yuan, a rise of 0.04% [6] - The 5-year and 2-year Treasury futures saw slight declines of 0.01% and 0.2%, respectively [6] Commodity Market - In the domestic commodity futures market, the main contracts showed mixed results, with polysilicon leading the gains, rising over 2% [6] - Other commodities like gold, silver, and soybean meal also saw increases of over 1% [6] - Lithium carbonate and other materials experienced declines, with lithium dropping over 3% [6] ETF Performance - The China Securities Convertible Bond Index rose by 0.11%, closing at 484.89 points [7] - The innovative drug ETFs saw significant gains, with the Huatai-PB ETF rising by 7.71% and the Guotai ETF by 7.27% [7] - Other ETFs in the communication sector experienced declines, with some dropping nearly 5% [7] Institutional Insights - Wanlian Securities noted a recovery in market confidence since mid-October, with active trading in technology sectors [8] - Morgan Stanley emphasized that A-share valuations remain attractive despite improvements in corporate profitability [8] - Dongguan Securities highlighted that the upcoming Fed rate cuts could attract international funds to emerging markets, enhancing the appeal of Chinese assets [8]
四点半观市 | 机构:权益资产配置环境整体趋向有利
Sou Hu Cai Jing·2025-10-31 08:22